BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37792663)

  • 21. Significance of tumor deposits combined with lymph node metastasis in stage III colorectal cancer patients: a retrospective multi-center cohort study from China.
    Pu H; Pang X; Fu J; Zheng R; Chen Y; Zhang D; Fang X
    Int J Colorectal Dis; 2022 Jun; 37(6):1411-1420. PubMed ID: 35595975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of classified extramural tumor deposits and extracapsular lymph node invasion in T3-4 colorectal cancer: a retrospective single-center study.
    Yamano T; Semba S; Noda M; Yoshimura M; Kobayashi M; Hamanaka M; Beppu N; Yano A; Tsukamoto K; Matsubara N; Tomita N
    BMC Cancer; 2015 Nov; 15():859. PubMed ID: 26545360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour budding and poorly differentiated clusters in colon cancer - different manifestations of partial epithelial-mesenchymal transition.
    Pavlič A; Boštjančič E; Kavalar R; Ilijevec B; Bonin S; Zanconati F; Zidar N
    J Pathol; 2022 Nov; 258(3):278-288. PubMed ID: 36062412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of tumor deposits on overall survival in colorectal cancer: Based on Surveillance, Epidemiology, and End Results database.
    Wu WX; Zhang DK; Chen SX; Hou ZY; Sun BL; Yao L; Jie JZ
    World J Gastrointest Oncol; 2022 Sep; 14(9):1699-1710. PubMed ID: 36187391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of metastatic tumor deposit foci in rectal cancer in the lateral pelvic lymph node area.
    Yamai D; Shimada Y; Nakano M; Ozeki H; Matsumoto A; Abe K; Tajima Y; Nakano M; Ichikawa H; Sakata J; Nagai T; Ling Y; Okuda S; Watanabe G; Nogami H; Maruyama S; Takii Y; Wakai T
    Int J Clin Oncol; 2023 Oct; 28(10):1388-1397. PubMed ID: 37481501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
    Sirinukunwattana K; Domingo E; Richman SD; Redmond KL; Blake A; Verrill C; Leedham SJ; Chatzipli A; Hardy C; Whalley CM; Wu CH; Beggs AD; McDermott U; Dunne PD; Meade A; Walker SM; Murray GI; Samuel L; Seymour M; Tomlinson I; Quirke P; Maughan T; Rittscher J; Koelzer VH;
    Gut; 2021 Mar; 70(3):544-554. PubMed ID: 32690604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can the tumor deposits be counted as metastatic lymph nodes in the UICC TNM staging system for colorectal cancer?
    Song YX; Gao P; Wang ZN; Liang JW; Sun Z; Wang MX; Dong YL; Wang XF; Xu HM
    PLoS One; 2012; 7(3):e34087. PubMed ID: 22461900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconsidering the prognostic significance of tumour deposit count in the TNM staging system for colorectal cancer.
    Wang S; Guan X; Ma M; Zhuang M; Ma T; Liu Z; Chen H; Jiang Z; Chen Y; Wang G; Wang X
    Sci Rep; 2020 Jan; 10(1):89. PubMed ID: 31919408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition.
    von Winterfeld M; Hoffmeister M; Ingold-Heppner B; Jansen L; Tao S; Herpel E; Schirmacher P; Dietel M; Chang-Claude J; Autschbach F; Brenner H; Bläker H
    Eur J Cancer; 2014 Nov; 50(17):2958-65. PubMed ID: 25281526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China.
    Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
    Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching.
    De Smedt L; Palmans S; Andel D; Govaere O; Boeckx B; Smeets D; Galle E; Wouters J; Barras D; Suffiotti M; Dekervel J; Tousseyn T; De Hertogh G; Prenen H; Tejpar S; Lambrechts D; Sagaert X
    Br J Cancer; 2017 Jan; 116(1):58-65. PubMed ID: 27884016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-resolution MRI-based radiomics analysis to predict lymph node metastasis and tumor deposits respectively in rectal cancer.
    Yang YS; Feng F; Qiu YJ; Zheng GH; Ge YQ; Wang YT
    Abdom Radiol (NY); 2021 Mar; 46(3):873-884. PubMed ID: 32940755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
    Huang L; David O; Cabay RJ; Valyi-Nagy K; Macias V; Zhong R; Wenig B; Feldman L; Weichselbaum R; Spiotto MT
    Clin Cancer Res; 2019 Mar; 25(6):1795-1808. PubMed ID: 30573692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours.
    Chen B; Zhang G; Lai J; Xiao W; Li X; Li C; Mok H; Li K; Wang Y; Cao L; Jia M; Ren C; Wen L; Wei G; Lin J; Li Y; Zhang Y; Chen X; Wu X; Zhang H; Li M; Liu J; Balch CM; Liao N
    EBioMedicine; 2021 Sep; 71():103542. PubMed ID: 34454403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buds, clusters, and transitions in 21st century colorectal carcinoma: revolution or reinvention?
    Feakins RM; Loughrey MB; Silver A
    J Pathol; 2023 Oct; 261(2):121-124. PubMed ID: 37565277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-interpreting tumour behaviour and the tumour microenvironment as normal responses to tissue disorganisation.
    Edwards PA
    J Pathol; 2023 May; 260(1):1-4. PubMed ID: 36811403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping the spreading routes of lymphatic metastases in human colorectal cancer.
    Zhang C; Zhang L; Xu T; Xue R; Yu L; Zhu Y; Wu Y; Zhang Q; Li D; Shen S; Tan D; Bai F; Zhang H
    Nat Commun; 2020 Apr; 11(1):1993. PubMed ID: 32332722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consensus molecular subtype transition during progression of colorectal cancer.
    van de Weerd S; Torang A; Zwager LW; Koelink PJ; Koster J; Bastiaansen BA; Lammers V; Longobardi C; Roodhart JM; van Krieken JH; Farina Sarasqueta A; Dekker E; Medema JP
    J Pathol; 2023 Nov; 261(3):298-308. PubMed ID: 37681286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour deposits are independently associated with recurrence in colon cancer.
    Hakki L; Khan A; Do E; Gonen M; Firat C; Vakiani E; Shia J; Widmar M; Wei IH; Smith JJ; Pappou EP; Nash GM; Paty PB; Garcia-Aguilar J; Weiser MR
    Colorectal Dis; 2024 Mar; 26(3):459-465. PubMed ID: 38263577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes.
    Zhuang A; Zhuang A; Chen Y; Qin Z; Zhu D; Ren L; Wei Y; Zhou P; Yue X; He F; Xu J; Ding C
    Elife; 2023 May; 12():. PubMed ID: 37158593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.